Literature DB >> 15541092

Leukocytapheresis treatment for pyoderma gangrenosum.

E Fujimoto1, N Fujimoto, K Kuroda, S Tajima.   

Abstract

A 42-year-old man presented with painful erythema with pustules and multiple small ulcers on the shins. He had suffered from ulcerative colitis (UC) and received oral glucocorticosteroid and salicylazosulfapyridine therapies for 7 years. Biopsy of the lesion demonstrated mixed cellular infiltrates with dominant neutrophils. The patient was diagnosed with pyoderma gangrenosum (PG) and underwent leukocytapheresis (LCAP), an extracorporeal leucocyte removal therapy, once a week for 5 weeks without changing the doses of the oral medications. The skin lesions as well as clinical signs of UC rapidly improved after LCAP, and no recurrence was seen during a follow-up period. There were no major complications during LCAP. LCAP will provide an effective and safe tool for the treatment of PG.

Entities:  

Mesh:

Year:  2004        PMID: 15541092     DOI: 10.1111/j.1365-2133.2004.06249.x

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  11 in total

Review 1.  Current topics on therapeutic apheresis.

Authors:  Ken Yamaji
Journal:  J Artif Organs       Date:  2010-04-03       Impact factor: 1.731

2.  Successful treatment of ulcerative colitis complicated by Sweet's syndrome by corticosteroid therapy and leukocytapheresis.

Authors:  Tomohiro Terai; Mitsushige Sugimoto; Satoshi Osawa; Ken Sugimoto; Takahisa Furuta; Shigeru Kanaoka; Mutsuhiro Ikuma
Journal:  Clin J Gastroenterol       Date:  2011-03-29

3.  Evidence-based clinical practice guidelines for inflammatory bowel disease.

Authors:  Katsuyoshi Matsuoka; Taku Kobayashi; Fumiaki Ueno; Toshiyuki Matsui; Fumihito Hirai; Nagamu Inoue; Jun Kato; Kenji Kobayashi; Kiyonori Kobayashi; Kazutaka Koganei; Reiko Kunisaki; Satoshi Motoya; Masakazu Nagahori; Hiroshi Nakase; Fumio Omata; Masayuki Saruta; Toshiaki Watanabe; Toshiaki Tanaka; Takanori Kanai; Yoshinori Noguchi; Ken-Ichi Takahashi; Kenji Watanabe; Toshifumi Hibi; Yasuo Suzuki; Mamoru Watanabe; Kentaro Sugano; Tooru Shimosegawa
Journal:  J Gastroenterol       Date:  2018-02-10       Impact factor: 7.527

4.  Alteration in the gene encoding protein tyrosine phosphatase nonreceptor type 6 (PTPN6/SHP1) may contribute to neutrophilic dermatoses.

Authors:  Andrew B Nesterovitch; Zsuzsa Gyorfy; Mark D Hoffman; Ellen C Moore; Nada Elbuluk; Beata Tryniszewska; Tibor A Rauch; Melinda Simon; Sewon Kang; Gary J Fisher; Katalin Mikecz; Michael D Tharp; Tibor T Glant
Journal:  Am J Pathol       Date:  2011-03-04       Impact factor: 4.307

Review 5.  Treatment of inflammatory bowel disease: a review of medical therapy.

Authors:  Patricia L Kozuch; Stephen B Hanauer
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

6.  Leukocytapheresis Therapy Improved Cholestasis in a Patient Suffering from Primary Sclerosing Cholangitis with Ulcerative Colitis.

Authors:  Minoru Itou; Keiichi Mitsuyama; Takumi Kawaguchi; Yoshinobu Okabe; Hideya Suga; Junya Masuda; Hiroshi Yamasaki; Kotaro Kuwaki; Eitaro Taniguchi; Masaru Harada; Osamu Tsuruta; Michio Sata
Journal:  Case Rep Gastroenterol       Date:  2009-04-15

Review 7.  Pyoderma gangrenosum: pathogenetic oriented treatment approaches.

Authors:  Uwe Wollina; Georgi Tchernev
Journal:  Wien Med Wochenschr       Date:  2014-06-05

8.  Leukocytapheresis for the treatment of active pouchitis: a pilot study.

Authors:  Yasumi Araki; Keiichi Mitsuyama; Takaaki Nagae; Yuji Tou; Motonori Nakagawa; Yasue Iwatani; Masakazu Harada; Hiroyuki Ozasa; Michio Sata; Toshihiro Noake
Journal:  J Gastroenterol       Date:  2008-07-23       Impact factor: 7.527

Review 9.  Cytapheresis for pyoderma gangrenosum associated with inflammatory bowel disease: A review of current status.

Authors:  Kentaro Tominaga; Kenya Kamimura; Hiroki Sato; Masayoshi Ko; Yuzo Kawata; Takeshi Mizusawa; Junji Yokoyama; Shuji Terai
Journal:  World J Clin Cases       Date:  2020-06-06       Impact factor: 1.337

Review 10.  Pyoderma gangrenosum--a review.

Authors:  Uwe Wollina
Journal:  Orphanet J Rare Dis       Date:  2007-04-15       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.